ILD was detected in about half of AAV cases, and one-third had fibrotic ILD, indicating a substantial pulmonary fibrosis ...

Isolated antineutrophil cytoplasmic antibody-associated interstitial lung disease is an increasingly recognized fibrotic ILD phenotype.

The fatigue and breathlessness program specific to interstitial lung disease is feasible, acceptable, and clinically effective.

Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with ...

Rural ILD patients experience significant diagnostic and treatment delays compared to urban counterparts, highlighting access challenges. Telehealth shows promise in improving access to ILD care, ...

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.

Please provide your email address to receive an email when new articles are posted on . A CHEST project hopes to educate health care workers on best practices in interstitial lung disease diagnosis.

Neil B. Minkoff, MD: Dr Hummers, please share the prevalence of chronic fibrosis ILD [interstitial lung disease] with the progressive phenotype? Laura Hummers, MD: It’s tricky to determine a phenotype ...

New-onset interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) occurred at a rate of 3.83 cases per 100 person-years, with detection noted up to 10 years post-negative screening ...